235 results on '"Perrotta, Fabio"'
Search Results
2. Psoriatic Arthritis Acceptable Symptoms State: Does Sex Make a Difference?
3. Clinical Characteristics of “Severe” Peripheral Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort
4. Assessment of Patient–Physician Interactions in Psoriatic Arthritis: National Results of the ASSIST Study
5. PET imaging in the psoriasis and psoriatic arthritis field: un update
6. Sirtuins and Cellular Senescence in Patients with Idiopathic Pulmonary Fibrosis and Systemic Autoimmune Disorders
7. Two sides of management recommendations for psoriatic arthritis
8. Identification of the Minimal Disease Activity Domains Achieved Based on Different Treatments in Psoriatic Arthritis
9. Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis
10. Lung Microbiome as a Treatable Trait in Chronic Respiratory Disorders
11. The Conundrum of Psoriatic Arthritis: a Pathogenetic and Clinical Pattern at the Midpoint of Autoinflammation and Autoimmunity
12. Psoriatic Arthritis in Males and Females: Differences and Similarities
13. Sequencing of Biologic and Target Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic Arthritis: Are we Ready to Redefine the Treatment Strategy? A Perspective
14. Bite Damage to the Rigid Bronchoscope: A Report and Physics of an Extremely Rare Event
15. Constrictive Pericarditis With Massive Calcification in Systemic Sclerosis Treated With Pericardiectomy: A Case Report
16. Patient reported outcomes in early vs late diagnosis of psoriatic arthritis
17. Dactylitis and Early Onset Psoriasis in Psoriatic Arthritis: Are they Markers of Disease Severity? A Clinical Study
18. Clinical Characteristics of Potential “Difficult-to-treat” Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort
19. Treatment of benign endobronchial tumors: when, how, and why. Insights, experiences, and interventional pulmonology strategies
20. The evolving role of the patient for health management: from the insight to the co-creation of solutions
21. Diagnostic Accuracy of Ultrasound Guided Percutaneous Pleural Needle Biopsy for Malignant Pleural Mesothelioma
22. Frailty in Patients With Lung Cancer: A Systematic Review and Meta-Analysis
23. Molecular Diagnostic Yield and Safety Profile of Ultrasound-Guided Lung Biopsies: A Cross-Sectional Study.
24. Genomic Profiling for Predictive Treatment Strategies in Fibrotic Interstitial Lung Disease.
25. MRI Assessment of Extra-axial Findings at Pelvic Sites in a Group of Axial-SpA Patients
26. Multidisciplinary Approach to the Diagnosis of Idiopathic Interstitial Pneumonias: Focus on the Pathologist’s Key Role
27. Potential role of SIRT-1 and SIRT-3 as biomarkers for the diagnosis and prognosis of idiopathic pulmonary fibrosis
28. Targeting Progression in Pulmonary Fibrosis: An Overview of Underlying Mechanisms, Molecular Biomarkers, and Therapeutic Intervention
29. Comorbidities in COPD: Current and Future Treatment Challenges
30. The “Climb” Towards Minimal Disease Activity in Psoriatic Arthritis
31. High-Flow Nasal Cannula System in Respiratory Failure Associated with Interstitial Lung Diseases: A Systematic Review and Narrative Synthesis.
32. Sirtuins and Cellular Senescence in Patients with Idiopathic Pulmonary Fibrosis and Systemic Autoimmune Disorders.
33. Sensitivity and Specificity of Composite Indices of Remission in Male and Female Patients With Psoriatic Arthritis: A Multicenter Cross-Sectional Study of Longitudinal Cohorts
34. Sex-related differences in psoriatic arthritis
35. SARS-CoV-2 IgM False-Positivity in a Psoriatic Arthritis Patient Seropositive for Rheumatoid Factor and ACPA: An Interference of Immune Response?
36. Sensitivity and Specificity of Composite Indices of Remission in Male and Female Patients With Psoriatic Arthritis: A Multicenter Cross-Sectional Study of Longitudinal Cohorts.
37. Targeting Progression in Pulmonary Fibrosis: An Overview of Underlying Mechanisms, Molecular Biomarkers, and Therapeutic Intervention.
38. The Plastic Interplay between Lung Regeneration Phenomena and Fibrotic Evolution: Current Challenges and Novel Therapeutic Perspectives.
39. How do we treat psoriatic arthritis in the era of GRAPPA recommendations: predictive factors for bDMARDs usage in PsA patients in a real life setting
40. Exploring the Network between Adipocytokines and Inflammatory Response in SARS-CoV-2 Infection: A Scoping Review
41. Triple jump for the optimal management of psoriatic arthritis: diet, sleep and exercise – a review
42. Smart Sensors and Microtechnologies in the Precision Medicine Approach against Lung Cancer
43. Ultrasonographic Evaluation of Entheseal Fibrocartilage in Patients with Psoriatic Arthritis, Athletes and Healthy Controls: A Comparison Study
44. Adiponectin Increase in Patients Affected by Chronic Obstructive Pulmonary Disease with Overlap of Bronchiectasis
45. Adiponectin, Leptin, and Resistin Are Dysregulated in Patients Infected by SARS-CoV-2
46. Strategies Tackling Viral Replication and Inflammatory Pathways as Early Pharmacological Treatment for SARS-CoV-2 Infection: Any Potential Role for Ketoprofen Lysine Salt?
47. Sequencing of Biologic and Target Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic Arthritis: Are we Ready to Redefine the Treatment Strategy? A Perspective
48. Complete response to pembrolizumab as a single agent in a patient with stage III NSCLC with high PD-L1 expression: a case report
49. Effects of Different Corticosteroid Doses in Elderly Unvaccinated Patients with Severe to Critical COVID-19
50. Mucolytic and Antioxidant Properties of Carbocysteine as a Strategy in COVID-19 Therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.